Alliancebernstein L.P. Enzo Biochem Inc Transaction History

Alliancebernstein L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$2.86 - $3.61 $162,734 - $205,409	-56,900 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$2.61 - $4.08 $9,657 - $15,096	-3,700 Reduced 6.11%	56,900 $196,000
Q3 2020 Nov 12, 2020	SELL	$2.02 - $3.02 $43,026 - $64,326	-21,300 Reduced 26.01%	60,600 $128,000
Q2 2020 Aug 13, 2020	BUY	$2.12 - $3.22 $46,640 - $70,840	22,000 Added 36.73%	81,900 $183,000
Q1 2020 May 14, 2020	BUY	$1.82 - $3.87 $44,590 - $94,815	24,500 Added 69.21%	59,900 $152,000
Q2 2019 Aug 14, 2019	BUY	$2.79 - $4.31 $8,649 - $13,360	3,100 Added 9.6%	35,400 $119,000
Q2 2018 Aug 13, 2018	BUY	$5.06 - $6.78 $5,060 - $6,780	1,000 Added 3.19%	32,300 $168,000
Q1 2018 May 14, 2018	SELL	$5.43 - $8.36 $330,198 - $508,371	-60,810 Reduced 66.02%	31,300 $172,000
Q4 2017 Feb 13, 2018	SELL	$8.15 - $10.55 $187,776 - $243,072	-23,040 Reduced 20.01%	92,110 $751,000
Q3 2017 Nov 13, 2017	BUY	$10.45 - $11.44 $1.2 Million - $1.32 Million	115,150	115,150 $1.21 Million

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $36.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.